The team that brought you Karuna – recently sold to Bristol-Myers Squibb for $14 billion – has set up a neuropsychiatry-focused biotech called Seaport Therapeutics. Karuna co-founder Daphne ...

An HT analysis suggests that March 10 is indeed early for such a breach, although it is not the earliest this breach has happened.

In his reporting career of over 20 years, Sanjeev K Jha has covered bureaucracy, politics, ISI activities in border areas, music and Bollywood. Presently, he covers crime in the national Capital.

Bristol-Myers Squibb has got its $14 billion acquisition of Karuna Therapeutics over the line, having had to withdraw and refile antitrust paperwork and contend with a shareholder lawsuit that ...